Carisma Therapeutics Inc - CARM Net Assets per Single Share

Graphic logo of Carisma Therapeutics Inc. (CARM)

Carisma Therapeutics (CARM) strives for global leadership in solid tumor therapy via CAR-macrophages. The book value per share demonstrates progress toward this goal, where -1.10 shows the current volume of the metric. However, development is hindered by cell culture automation complexities and the need for strict control over the express delivery of biomaterials, which creates certain operational barriers.

Carisma Tx (CARM): Share Book Value from 04/28/2023 to 10/25/2025

Carisma Therapeutics Inc - analytical breakdowns and key metrics (CARM)

- price and consensus price forecast:
Price Chart Carisma Tx|CARM - Fair Value Consensus
- market capitalization data:
Market Value Carisma Therapeutics Inc.|CARM - Real Price to Acquire Entire Company
- book capitalization data:
Net Assets per Single Share Carisma Therapeutics|CARM - Net Asset Value|Market Capitalization to Book Value Ratio carismatx.com|CARM - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Carisma Therapeutics|CARM - Long-Term Debt to Capital|Short-Term Debt to Equity Carisma Tx|CARM - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Carisma Therapeutics Inc.|CARM - Company Long-Term Liabilities|Company Short-Term Debts Carisma Therapeutics
Fundamental company valuation:carismatx.com - CARM
Manufactured products of Carisma Tx

Book value per share reflects the portion of equity attributable to a single security, allowing investors to assess the actual value of net assets independent of market speculation. By analyzing the historical trend of book value per share, one can determine whether the capital of Carisma Therapeutics (CARM) is eroding during the costly scaling of the CAR-M platform and its expansion into the solid tumor therapy segment.

Competitors of Carisma Therapeutics (CARM)

Net Assets per Single Share Argenx (ARGX)|BNTX: Accounting Value of a Share|ABVX (Abivax Corp) - Net Assets per Single Share|ADMA (admabiologics.com) - Accounting Value per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|ATXS: Book Value per Share|ENGN - Accounting Value per Share|RAPT: Book Value per Share|JBIO (Aerovate Therapeutics) - Book Value per Share|ACRS - Net Assets per Single Share|Accounting Value of a Share Kyverna Therapeutics Inc.|TLSA (Tiziana Life Sciences PLC) - Book Value per Share|Net Assets per Share CABA (Cabaletta Bio Inc)|Net Assets per Single Share VTYX|theratech.com - Net Assets per Share|AVTX: Net Assets per Single Share|ELDN - Accounting Value per Share|AGEN: Book Value per Share|Book Value per Share Climb Bio, Inc|ZURA - Accounting Value per Share|Accounting Value of a Share atyrpharma.com (ATYR)|Accounting Value per Share Adagene|Book Price of a Share ikenaoncology.com (IMA)|Book Value per Share Shattuck Labs|Accounting Value of a Share Equillium Inc EQ|CNTB (Connect Pharma) - Book Value per Share|IMUX: Net Asset Value per Share|Net Assets per Single Share atarabio.com ATRA|InflaRx (IFRX) - Accounting Value of a Share|XFOR (X4 Pharma) - Book Value per Share|Book Value per Share ACET|CELU - Net Assets per Single Share|Share Book Value inmunebio.com (INMB)|BRNS: Book Value per Share|KZR - Net Asset Value per Share|SAB Biotherapeutics, Inc - Accounting Value per Share|Akari Therapeutics, Plc (AKTX) - Book Value per Share|ENLV - Accounting Value per Share|Q32 Bio (QTTB) - Book Price of a Share|GOVX: Book Value per Share|Net Assets per Share Edesa Biotech Inc|Book Value per Share IBIO (iBio Corp)|Accounting Value per Share XTLB (XTL Bio)|Net Assets per Single Share BOLT|Net Assets per Share HCW Biologics, Inc. HCWB|APVO: Book Value per Share|AIM - Accounting Value per Share|ADTX: Book Value per Share|GRI (GRI Bio Corporation) - Book Value per Share|XRTX - Net Assets per Single Share|Accounting Value of a Share HIND|Net Assets per Single Share REVB (Revelation Biosciences, Inc.)|Accounting Value per Share INDP (Indaptus Therapeutics Inc)|Scinai (SCNI) - Net Assets per Single Share|Share Book Value CalciMedica Inc CALI|Book Value per Share Affimed Therapeutics (AFMD)|ALLK - Accounting Value of a Share|HOOK: Book Value per Share|IGMS (IGM Biosciences) - Book Value per Share|ITOS - Net Assets per Single Share|Accounting Value of a Share OCEA|Net Assets per Single Share TCBP (TC Biopharm)|Accounting Value per Share thirdharmonicbio.com (THRD)